Paracetamol + Tramadol 325mg/37.5mg, 487.5mg/56.7mg & 650mg/75mg Divule FDC

Paracetamol + Tramadol 325mg/37.5mg, 487.5mg/56.7mg & 650mg/75mg Divule FDC
Product Description

Intro

Dossier:
Indication:
Formulation:


Read more Show less

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Belgium
More specifications Fewer specifications

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile

More Products from SMB Laboratories SA (18)

  • Paracetamol + Tramadol or effervescent tablets : 325mg/37.5mg FDC

    Product Paracetamol + Tramadol or effervescent tablets : 325mg/37.5mg FDC

    Intro

    Dossier:
    Inidication:
    Formulation:

  • Paracetamol + Ibuprofen 500mg/200mg FDC divule

    Product Paracetamol + Ibuprofen 500mg/200mg FDC divule

    Intro

    Dossier:
    Inidication:
    Formulation: 
  • Tramadol hydrochloride 100mg, 150mg, 200mg ER pellets

    Product Tramadol hydrochloride 100mg, 150mg, 200mg ER pellets

    Intro

    Dossier:
    Indication:
    Formulation:

    SMB Laboratories S.A. offer a wide range of products which includes tramadol hydrochloride. Indication: Treatment of moderate to severe pain. Form: EC pellets in caps, once daily. Contact us for more information.
  • Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)

    Product Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)

    Intro

    Dossier:
    Indication:
    Formulation: 
  • Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC

    Product Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC

    Intro

    Dossier:
    Indication:
    Formulation:


     Innovative Fixed Dose Combination of Budesonide and Salmeterol at in two dosages : 240/20µg and 120/20µg (delivered dose) as dry powder for inhalation.Dossier : CTD
    Indication: Regular treatment of asthma where use of a combination (i...
  • Buprenorphine 2 mg, 8 mg sublingual tablets

    Product Buprenorphine 2 mg, 8 mg sublingual tablets

    Intro

    Dossier: 
    Indication: 
    Formulation: 


  • Cholecacliferol+calcium 1000IU/1000mg FDC

    Product Cholecacliferol+calcium 1000IU/1000mg FDC

    Intro

    Dossier:
    Indication:
    Formulation:

    SMB Laboratories S.A. offer a wide range of products which includes chlorhexidinl cholecacliferol+calcium (vit. D+Ca) (OTC). It belongs to vitamins category. Indication: Food supplement. Formulation: Chewable tablets. Packaging: packs of 1...
  • Cholecalciferol Capsules 5600IU; 125000IU; 25000IU

    Product Cholecalciferol Capsules 5600IU; 125000IU; 25000IU

    Intro

    Dossier:
    Indication:
    Formulation:

    Innovative cholecalciferol in sealed hard caspules witha dosage of either 5600IU; 12500IU or 25000IU per capsulesDossier : CTD
    Indication: Treatment of vitamin D deficiency, initial treatment of vitamin D deficiency, vitamin D deficie...
  • Cholecalciferol Drops 2400IU/ml; 7200IUml

    Product Cholecalciferol Drops 2400IU/ml; 7200IUml

    Intro

    Dossier:
    Indication:
    Formulation:

    Drops of choelcalciferol as oily solution in glass bottles at eitehr 2400IU/ml or 72000IU/ml Dossier : CTD (2400IU/ml); Food Supplement (7200IU/ml)
    Indication: Prophylaxis of a vitamin D deficiency disease, supportive treatment o...
  • Cholecalciferol Flapules 25.000IU; 50.000IU; 100.000IU

    Product Cholecalciferol Flapules 25.000IU; 50.000IU; 100.000IU

    Intro

    Dossier:
    Indication:
    Formulation:

    Innovative chlecalciferol containing oily substance at either 25000IU; 50000IU and 100000IUper 1ml flapule for oral adminsitration Dossier : CTD
    Indication: Treatment of vitamin D deficiency, initial treatment of vitamin D defici...
  • Fenofibrate 160mg, 200mg, 267mg Lidose

    Product Fenofibrate 160mg, 200mg, 267mg Lidose

    Intro

    Dossier:
    Indication:
    Formulation:

    SMB Laboratories S.A. offer a wide range of products which includes fenofibrate (RX). It belongs to cardiology category and it is a lidose®technology based product. Indication: Treatment of hypercholesterolaemia and hypertriglyceridaemia, ...
  • Pravastatin/Fenofibrate 40/160mg FDC

    Product Pravastatin/Fenofibrate 40/160mg FDC

    Intro

    Dossier:
    Indication:
    Formulation:

    SMB Laboratories S.A. offer a wide range of products which includes fenofibrate/pravastatin fixed dose combination (RX). It belongs to cardiology category. Indication: treatment of adult patients at high risk of coronary heart disease with...
show all 18 other products

SMB Laboratories SA resources (1)